Isomorphic Labs raises $600 Million in its Series A funding round to enhance its AI drug design engine and advance therapeutic programs. Led by Thrive Capital, this funding will support significant advancements in drug discovery and development.
Amount Raised
$600 Million
Round Type
Series A
LondonBiotechnologyArtificial IntelligenceMachine LearningInvestors
Description
Isomorphic Labs, an AI-first drug design and development company, has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation from GV and follow-on capital from existing investor, Alphabet. The funding will be utilized to enhance its AI drug design engine through advanced research and to scale the company's drug candidate pipeline. This significant investment aims to transform the industry by leveraging AI in drug discovery and development.
Quick answer
Isomorphic Labs raised $600 Million in a Series A round, dated March 31, 2025. Investors: Thrive Capital, GV and Alphabet. Isomorphic Labs is based in London, England, United Kingdom.
- How much did Isomorphic Labs raise?
- Isomorphic Labs raised $600 Million in a Series A round on March 31, 2025.
- Who invested in Isomorphic Labs?
- Thrive Capital, GV and Alphabet are named as investors in this round.
- What does Isomorphic Labs do?
- Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some..
- Where is Isomorphic Labs based and how big is it?
- Isomorphic Labs is based in London, England, United Kingdom. Fundz records about 420 employees.
- Who are the decision-makers at Isomorphic Labs?
- Fundz holds 2 contacts at Isomorphic Labs, including the Senior Talent Partner. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Artificial Intelligence around the same time
Companies in the same sectors as Isomorphic Labs that raised within 45 days of this round, from Fundz verified event records.
- Cursor raised an undisclosed amount (Funding Round) on April 21, 2025.
- Akido raised $60M (Series B) on May 15, 2025.
- PhaseV raised $50M (Series A) on May 13, 2025.
- Intrepid Labs raised $11M (Seed) on May 12, 2025.
- Carta Healthcare raised $18M (Funding Round) on May 7, 2025.
- Alphabiome raised $8M (Seed) on May 6, 2025.
Who to call at Isomorphic Labs, and when
A new round usually means Isomorphic Labs is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Isomorphic Labs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Isomorphic Labs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Isomorphic Labs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Isomorphic Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansIsomorphic Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.